Translational control of memory processes is a tightly regulated process where the coordinated interaction and 47 modulation of translation factors provides a permissive environment for protein synthesis during memory 48 formation. Existing methods used to block translation lack the spatiotemporal precision to investigate cell-49 specific contributions to consolidation of long-term memories. Here, we have developed a novel chemogenetic 50 mouse resource for cell type-specific and drug-inducible protein synthesis inhibition (ciPSI) that utilizes an 51 engineered version of the catalytic kinase domain of dsRNA-activated protein (PKR). ciPSI allows rapid and 52 reversible phosphorylation of eIF2α causing a block on general translation by 50% in vivo. Using this resource,
141 that is constitutively active and does not require either double-stranded RNA or dimerization for activation 21 .
142
We designed our ciPSI multicistronic construct with NS3/4 protease 22 , EGFP, and inducible PKR (iPKR) 143 transgenes separated by self-cleaving 2A proteinase that allows translation of individual elements by ribosome 144 skipping 23 (Supplemental Fig. 1b) . To test the inhibition of global translation in vitro, newly synthesized proteins 145 were metabolically labeled with S 35 methionine after starvation. In cells transfected with iPKR and NS3/4A, 146 iPKR was degraded by NS3/4 and de novo translation was equivalent to the control cells, whereas cells 147 transfected with iPKR plasmid alone in the absence of NS3/4A had substantially reduced translation by about 148 60%. Unmodified PKR kinase domain (PKRk) similarly reduced de novo translation relative to controls, but the 149 PKRk levels were non-responsive to NS3/4 protease ( Supplementary Fig. 1c ). As predicted, PKRk fragment 150 was detected only in lysates from cells transfected with either unmodified PKRk or modified iPKR 151 (Supplemental Fig. 1d ).
153
We next knocked in the ciPSI multicistronic cassette into the first intron of the mouse Eef1a1 genomic 154 locus 24 with two modifications ( Fig. 1b and Supplementary Fig. 2a and b ). First, EGFP was substituted with an 155 5 EGFP-L10 fusion to use as a fluorescent marker of cells expressing ciPSI and to eventually enable translating 156 ribosome affinity purification (TRAP) profiling 25 . Second, a STOP cassette flanked by loxP sites preceded the 157 ciPSI cassette to allow cell type-specific disruption of protein synthesis when combined with Cre driver mouse 158 lines and/or Cre-expressing viruses. These modifications had no effect on expression of iPKR (data not 159 shown). A mouse Nestin (Nes) Cre-driver line 26 was bred with the ciPSI line to generate transheterozygote 160 Nes.iPKR pan-neuronal ciPSI knock-in mice, which were viable and fertile. The Nes-iPKR mice expressed 161 EGFP-L10 in all neurons in the amygdala, as marked by complete overlap with NeuN staining (Fig. 1d ), as well 162 as in cortical areas such as the anterior cingulate cortex and somatosensory cortex, and hippocampal areas, 163 CA1 and CA3, and the dentate gyrus (Supplemental Fig. 2c-g 
167
To test the efficiency of ciPSI in blocking protein synthesis ex vivo, amygdala slices of Nes.iPKR mice 168 and wild-type (WT) mice were subjected to bio-orthogonal non-canonical amino-acid tagging (BONCAT) 27 of 169 newly synthesized proteins. Nes.iPKR amygdala slices treated with 1 µM ASV exhibited a sharp decline in de 170 novo translation (~20%) compared with controls ( Fig. 2a ). Because BONCAT uses azidohomoalanine (AHA), a 171 synthetic methionine analog, which can get outcompeted by endogenous methionine in vivo, this method does 172 not sufficiently label de novo translation in vivo. Thus, an independent method of labeling de novo translation, 173 surface sensing of translation (SUnSET) 28 , that measures translation elongation and is amenable for in vivo 174 labeling, was used to test ciPSI efficiency in awake behaving mice. SUnSET immunoblot showed that 175 Nes.iPKR mice centrally infused with 150 pg ASV exhibited a robust decrease in protein synthesis (~50%) 176 compared to controls (Fig. 2b) . The inhibition of protein synthesis was concomitant with a specific increase in 177 phosphorylation of eIF2α at 1h post ASV treatment both ex vivo ( Fig. 2c ) and in vivo (Fig. 2d) , with no effect 178 on either the extracellular signal regulated kinase (ERK1/2) or mechanistic target of rapamycin (mTORC1) 179 pathways ( Fig. 2d ). Next, we investigated the ASV pharmacokinetics in Nes.iPKR amygdala lysates by 180 harvesting tissue at increasing time points after drug infusion. We found that peak expression of iPKR is 181 reached at 0.5h, which steadily declines at 1h and 3h and is completely degraded by 6h ( Fig. 2e ).
182
Subsequently, phosphorylation of eIF2α steadily increased at 0.5h and 1h and then declined to baseline at 3h.
183
As a result of phosphorylation of eIF2α, proteins whose transcripts harbor uORFs, specifically ATF4 and 184 GADD34, accumulated and remained at higher levels compared to control until 3h ( Fig. 2e ). GADD34 is the 185 regulatory subunit of the eIF2α phosphatase 17 , and the negative feedback due to increased GADD34 levels 186 combined with the degradation of iPKR by NS3/4 protease at 3h time point might be responsible for reduced 187 phosphorylation of eIF2α below the control ( Fig. 2e ). We also probed for cFos to assess whether cFos levels 188 change with ciPSI, and found that cFos levels significantly decrease below baseline at 3h and 6h following 189 ASV treatment ( Fig. 2e) indicating general translation suppression. 190 191 memory paradigms including contextual and auditory threat conditioning and conditioned taste aversion 14 , 268 indicating that phosphorylation of eIF2α is a malleable constraint on protein synthesis during memory 269 consolidation. Therefore, we virally delivered Camk2α.Cre.EGFP bilaterally to the LA of floxed phosphomutant 270 eIF2α (S51A) mice 42 (Fig. 5a ). Targeting phosphomutant eIF2α S51A expression in LA CamK2α+ neurons led 271 to a significant increase in de novo translation in homozygous CamK2α.eIF2α (A/A) but not in heterozygous 272 CamK2α.eIF2α (A/+) neurons, as assessed with in vivo SUnSET (Fig. 5b) , and also led to a decrease in 273 phosphorylated eIF2α (Supplemental Fig. 6a ). Congruently, although all of the mice learned auditory threat 274 conditioning ( Fig. 5c ), homozygous CamK2α.eIF2α (A/A) mice exhibited significantly higher freezing responses 275 to the conditioned tone in the LTM test, indicating more robust memory compared to wild-type controls (Fig. 276 5e-f). We next sought to correct the memory deficit in the CamK2α iPKR mice by introducing phosphomutant 277 eIF2α, and thus generated CamK2α.iPKR eIF2α (A/+) and CamK2α.iPKR eIF2α (A/A) animals by injecting 278 AAV.CamK2α.Cre in the LA of mice double transgenic for iPKR and eIF2α S51A. Memory deficits in the 279 CamK2a.iPKR mice were completely rescued by dephosphorylating both alleles of eIF2α, but was unaltered by 280 dephosphorylating one allele of eIF2α ( Fig. 5e-f ). This indicated that the translation tone and LTM 281 consolidation process is set by the phosphorylation of eIF2α, even when the abundance of phosphorylatable 282 eIF2α is reduced by half, and confirmed that the memory deficit caused by iPKR is through the phosphorylation 283 of eIF2α and not due to non-specific cellular toxicity.
285
Notably, the memory enhancement in the CamK2α.eIF2α (A/A) mice came with a cost. We found that 286 the dysregulated increase in translation tone in CamK2α.eIF2α (A/A) mice resulted in impaired behavioral 287 flexibility during the tone offset in LTM test. CamK2α.eIF2α (A/A) mice freeze starting at tone onset, but 288 continue to freeze after the tone offset during inter-trial interval epochs (Supplemental Fig. 6b and Fig. 5g ).
289
This failure to switch off defensive state is triggered only after the onset of first tone while at pre-conditioned 290 stimulus (CS) the animals have normal motor behavior, indicating absence of generalized anxiety or contextual 291 threat response. We next tested CamK2α. Finally, we addressed whether lost memories can be rescued with artificial reactivation 43 of LA 300 CamK2α+ principal neurons. Designer drug activated by designer drug (DREADD) hM3Dq mediated neuronal 301 activation engages the mitogen activated protein kinases, ERK1/2, and mTORC1 pathways that are positively 302 associated with protein synthesis 44, 45 . We injected a cocktail of AAV.CamK2α.Cre together with 303 AAV.hSyn.DIO.hM3Dq.mCherry into the LA of iPKR knock-in mice ( Fig. 6a ). DREADD agonist C21 46 304 significantly increased de novo translation in CamK2α+ neurons of CamK2α.iPKR hM3Dq mice compared to 305 vehicle treated group (Fig. 6b ). We then trained CamK2α.iPKR hM3Dq, CamK2α.hM3Dq, and wild-type 306 control mice in a differential threat conditioning paradigm that involves three interleaved presentations of a 307 paired tone (CS+) and an unpaired tone (CS-) in a single session ( Fig. 6c-d ). Consistent with earlier data, post-308 training ASV infusion impaired LTM and led to a significant decline in freezing response to paired tone ( Fig. 6f -309 g). 48h after LTM1 test, we re-tested the animals for LTM2 in a different context following chemogenetic 310 activation of hM3Dq receptors in the CamK2α+ neurons using agonist C21. We found that although artificial 311 reactivation of CamK2α+ neurons recovered CS+ LTM, it led to stimulus generalization and resulted in 312 generalized defensive freezing response to CS-( Fig. 6h ) that reflected in a significant decline in threat 313 discrimination index ( Fig. 6i 
318
To further understand what happens when eIF2α-controlled general translation in LA principal neurons 319 is boosted during consolidation of a complex memory, we explored differential threat conditioning in CamK2α 320 eIF2α S51A mice (Supplemental Fig. 7c ). We found that whereas homozygous CamK2α.eIF2α (A/A) mice can 321 discriminate between CS+ and CS-during LTM, they have a significantly increased freezing response to CS-.
322
On the other hand, CamK2α wild-type mice robustly discriminated CS+ from CS-and displayed negligible 323 freezing response to CS-(Supplemental Fig. 7d ). The enhanced CS-response in theCamK2α.eIF2α (A/A) 324 mice resulted in a poor discrimination index (Supplemental Fig. 7e ). We next examined the freezing during ITI, 325 and found that similar to earlier results with simple threat conditioning, CamK2α.eIF2α (A/A) exhibited a 326 significantly increased freezing response following tone offset, indicating behavioral inflexibility (Supplemental 327 Fig. 7f -g). These findings indicate that the precision of a memory trace is contributed by the finely regulated 328 translation program in LA CamK2α+ neurons during memory consolidation.
330 331 Discussion

332
Protein synthesis is metabolically expensive and thus is tightly regulated at the level of initiation but 333 until now, an effective chemogenetic tool to block protein synthesis has been lacking, which has limited 334 investigation of cell autonomous protein synthesis in physiological processes. To address this issue, we have 335 bioengineered a spatiotemporally precise chemogenetic resource for rapidly and reversibly blocking cell 336 autonomous protein synthesis via phosphorylation of eIF2α. Phosphorylation of eIF2α is a tightly regulated 337 molecular event that acts as a master effector of the integrated stress response. Using our chemogenetic iPKR 338 mouse resource, we made several notable discoveries: 1) Temporally structured pan-neuronal protein 339 synthesis is required for long-term memory consolidation. Recent long-term memory examined 24 hours after 340 training is most sensitive to protein synthesis disruption in the first hour after training; 2) Blocking de novo 341 translation in CamK2α+ principal neurons within lateral amygdala disrupts long-term memory consolidation.
342
This block of memory consolidation can be rescued by either using the eIF2B activator ISRIB or by 343 dephosphorylating both alleles of eIF2α; 3) Expressing a biallelic phosphomutant eIF2α in CamK2α+ principal 344 neurons results in enhanced strength of the memory, but introduces behavioral inflexibility and a generalized 345 defensive response for an unpaired or safe tone; 4) Artificial reactivation of LA CamK2α+ neurons 24h after 346 protein synthesis inhibition recovers lost memory for the paired tone but causes stimulus generalization.
348
Protein synthesis dependence during memory consolidation 349 We found that too little or too much of phosphorylation of eIF2α causes aberrant memory storage and 350 expression. A parsimonious interpretation of our data is that state-dependent modulation of eIF2α 351 phosphorylation is critical for a finely tuned translation program supporting the associative memory. eIF2α 352 phosphorylation itself is a homeostatic process wherein the phosphorylation event triggers the synthesis of the 353 eIF2α dephosphorylating enzyme GADD34, bringing the system back to a lower state of eIF2α 354 phosphorylation. Our data is consistent with Batista et al (2016) showing that phosphorylation of eIF2α causes 355 a block of general translation 47 . In contrast, Jiang et al (2010) 15 reported that chemogenetic dimerization of 356 FKBP-PKR (fPKR) induced phosphorylation eIF2α by 1.5 fold without blocking general translation and thus, 357 they attributed the memory deficit in fPKR expressing animals to ATF4 expression. It is possible that because 358 these investigators injected the drug inducer of fPKR (AP20187) 2h before radioisotope S 35 methionine 359 injection i.p., the sensitive time window for protein synthesis disruption was missed during labeling. Compared 360 to fPKR, PKR kinase domain (PKRk) is more effective in suppressing translation because it not only directly 361 phosphorylates eIF2α, but it also interacts with and phosphorylates endogenous full-length PKR, further 362 boosting eIF2α phosphorylation 48 . In our system, central infusion of ASV resulted in 2-fold increase in 363 phosphorylated eIF2α, which resulted in a robust 50% decrease of general translation as assessed with in vivo 364 SUnSET that involved local infusion of puromycin directly into lateral amygdala. Our convergent data from a 365 parallel strategy of cell autonomous protein synthesis inhibition in LA CamK2α+ neurons using a synthetic 366 micro-RNA against eIF4E provides further support for the requirement of de novo protein synthesis in long-367 term memory consolidation. Nonetheless, we also observed an increase in ATF4 levels following 368 phosphorylation of eIF2α and cannot exclude the possibility that the memory deficit in the iPKR transgenic 369 mice is in part due to upregulated translation of transcripts containing uORFs, such as ATF4 and the ensuing 370 repression of CREB-regulated genes.
372 Memory generalization and behavioral inflexibility as a result of dysregulated translation 373
Several studies have used IEG-based engram cell targeting approaches to interrogate the nature of 374 memory formation and recall. Artificial reactivation of conditioned threat engram cells in LA using optogenetics 375 has been shown to recover memories previously lost by protein synthesis inhibition using anisomycin 49, 50 . Our 376 chemogenetic iPKR mouse resource is not amenable for the engram cell targeting approach because the 377 engram cells by definition need to be tagged during training event for iPKR expression, a process dependent 378 on de novo transcription and translation. Nonetheless, our results show that artificial reactivation of previously 379 translation-inhibited CamK2α+ neurons in LA results in memory recovery, but at the cost of stimulus 380 generalization. We propose that learning-induced somatic and synaptic protein synthesis functions to stabilize 381 the connections between the pathway-specific afferents from conditioned tone processing brain regions 382 (auditory cortex and auditory thalamus) to amygdalar engram cells in such a way that the conditioned tone can 383 access and activate the downstream neuronal network in the LA during recall. This natural cue-elicited 384 neuronal reactivation is incompletely recapitulated by artificial reactivation of LA neurons, such that there is 385 imprecise restoration of the memory, perhaps due to a lack of reinstatement of synapse specificity of the 386 original memory trace. Phospho-mutant eIF2α mice, with a rigid increase in translation in LA principal neurons, 387 also exhibit stimulus generalization and behavioral inflexibility at tone offset. Taken together, our data indicate 388 that a finely tuned translation program in the amygdala is required to coordinate the stability and precision of 389 the long-term memory trace.
391 Model of protein synthesis regulation during long-term memory consolidation 392
Based on our data, we propose the following cellular/molecular model of protein synthesis regulation in 393 lateral amygdala during long-term consolidation. Cued threat conditioning leads to a coordinated increase in 394 protein synthesis in CamK2α+ neurons in the soma and in local subcellular compartments, such as dendritic 395 spines and axons. This results in robust memory strength and precision ( Fig. 7a ). Chemogenetic inhibition of 396 protein synthesis using iPKR blocks general translation in LA CamK2α+ neurons resulting in memory loss ( Fig.   397 7b). Expression of biallelic phosphomutant eIF2α in LA CamK2α+ neurons, although insensitive to iPKR-398 mediated eIF2α phosphorylation, results in an aberrant increase in basal translation. This leads to robust 399 memory strength, but low memory precision. (Fig. 7c ). Artificial chemogenetic reactivation of CamK2α+ 400 neurons following inhibition of protein synthesis leads to an increase in protein synthesis, but does not 401 recapitulate learning-induced local translation, thus causing memory generalization. This is manifested as 402 normalized memory strength and low memory precision ( Fig. 7d ).
404
We have used multi-pronged chemogenetic approaches to investigate the translational control of long-405 term threat memories. Future studies will be required to elucidate how protein synthesis regulation occurs in 406 genetically defined and functionally coherent cell types within the memory network during long-term memory 
415
NS3/4 protease, iPKR, and GFP were amplified using Phusion polymerase (NEB) and cloned into peGFP-N1 416 vector (Clontech) using appropriate restriction enzymes (NEB). All constructs were verified by sequencing.
417
Purifications were done using PCR extraction kit (Qiagen). The ligations were performed with Quick Ligase kit 418 (NEB) and the products were transformed into chemically competent TOP10 cells (Invitrogen) that were grown 419 in LB medium containing 35 mg/ml Kanamcyin (Sigma). The mammalian expression constructs were sub-420 cloned into the gene targeting plasmids as previously reported 31 . The final construct was extracted with phenol: 421 chloroform: isoamyl alcohol (25:24:1), precipitated in 70% ethanol and dissolved in Tris-EDTA buffer.
423
Cell culture and transfection 424 293T cells were grown in a 24-well plate in growth medium (Invitrogen) supplemented with 10% fetal bovine 425 serum (Invitrogen) to have 90% confluency on the day of transfection. Transfection was carried out with 1 μg of 426 a reference plasmid using 2 μL 293Tfectin reagent (Invitrogen). The amounts of the remaining plasmids were 427 adjusted to have the same molarity per well. Cells were lysed on ice in phosphate-buffered saline supplied with 428 1% Triton X-100 (Sigma) and inhibitors against proteases (Pierce, 78437) phosphatases (Pierce, 78420) and 429 translation machinery (100 μg/ml Cycloheximide, Sigma); and the cytosolic extracts were isolated after 430 precipitating the insoluble fraction. The protein concentrations were measured using BCA protein assay 431 (Pierce). 
442 Animals
443
Mice were provided with food and water ad libitum and were maintained in a 12h/12h light/dark cycle at New 444 York University at stable temperature (78 o F) and humidity (40 to 50%). All mice were backcrossed to C57Bl/6J 445 strain for at least 5 generations. Nestin Cre transgenic mice (stock #003771) were obtained from Jackson 446 laboratory as previously described 34 behaving mice using internal cannula with 1 mm projection. For BONCAT ex vivo assays, azidohomoalanie 468 (AHA) (Fisher, NC0667352) was dissolved in distilled water at 100 mM. 1 mM AHA was bath applied to 469 amygdala slices in ACSF (125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 25 mM glucose, 1 470 mM MgCl 2 and 2 mM CaCl 2 ). DREADD actuator, agonist C21 (Tocris), was dissolved in DMSO at 40 mg/ml 471 concentration and freshly diluted in saline and administered to mice at 1 mg/kg i.p. 25 mM PKR inhibitor C16 472 (Cal-biochem) was dissolved in DMSO and diluted in saline to a final DMSO concentration of 0.5%. PKR 473 inhibitor C16 was administered i.p. at a dosage 5 mg/kg 30 min before training when specified. ISRIB was 474 dissolved in 1:1 PEG400:DMSO and injected in mice at 2.5 mg/kg i.p as previously described 33 . Doxycycline 475 was prepared in rodent chow (Bio-Serv) at 40 mg/kg and this diet was provided to the mice in 4Ekd group for 476 two weeks following surgery. 
502 Electrophysiology
503
The electrophysiology experiments were performed as previously described 29, 51 and mice were between 2 and 
527
The parameters tested were: distance traveled and the ratio of center to total distance at three epochs. 558 mm to -2.06 mm] were prepared in cold (4 o C) carbooxygenated (95% O 2 , 5% CO 2 ) cutting solution ( 110 mM 559 sucrose, 60 mM NaCl, 3 mM KCl, 1.25 mM NaH 2 PO 4 , 28 mM NaHCO 3 , 5 mM Glucose, 0.6 mM Ascorbate, 7 560 mM MgCl 2 and 0.5 mM CaCl 2 ) using a VT1200S vibratome (Leica). Amygdala was micro-dissected from the 561 brain slices and sonicated in ice-cold homogenization buffer (10 mM HEPES, 150 mM NaCl, 50 mM NaF, 1 562 mM EDTA, 1 mM EGTA, 10 mM Na 4 P 2 O 7 , 1% Triton X-100, 0.1% SDS and 10% glycerol) that was freshly 563 supplemented with 10 μl each of protease inhibitor (Sigma) and phosphatase inhibitor (Sigma) per ml of 564 homogenization buffer. Protein concentrations were measured using BCA assay (GE Healthcare). Samples 565 were prepared with 5X sample buffer (0.25 M Tris-HCl pH6.8, 10% SDS, 0.05% bromophenol blue, 50% 566 glycerol and 25% -β mercaptoethanol) and heat denatured at 95 o C for 5 min. 40 μg protein per lane was run 567 in pre-cast 4-12% Bis-Tris gels (Invitrogen) and subjected to SDS-PAGE followed by wet gel transfer to PVDF 568 membranes. After blocking in 5% non-fat dry milk in 0.1M PBS with 0.1% Tween-20 (PBST), membranes were 569 probed overnight at 4°C using primary antibodies (goat anti-biotin (abcam ab53494), rabbit anti-p-eIF2α S51 570 (Cell Signaling #9721), rabbit anti-t-eIF2α (Cell Signaling #9722), rabbit anti-PKR (abcam ab32506, Cell 571 Signaling #3072), rabbit ATF4 (Santa Cruz sc-390063), rabbit anti-pERK1/2 Thr202/Tyr204 (Cell Signaling 572 #9101), rabbit anti-ERK1/2 (Cell Signaling #9102), rabbit anti-pS6 Ser(240/Ser244 (Cell Signaling #5364), 573 mouse anti-S6 (Cell Signaling #2317), mouse anti-puromycin (Millipore MABE343), rabbit anti-Gadd34 574 (Proteintech #10449-1-AP), mouse anti-β tubulin (Sigma #T8328) and mouse anti-β actin (Sigma #A1978).
575
After washing 3 times in 0.1% PBST, membranes were probed with horseradish peroxidase-conjugated 576 secondary IgG (1:5000) (Millipore) for 1h at RT. Signals from membranes were detected with ECL 577 chemiluminescence (Thermo Pierce) using Protein Simple instrument. Exposures were set to obtain signals at 578 the linear range and then normalized by total protein and quantified via densitometry using ImageJ software.
580 Metabolic labeling in vitro 581
To visualize the inhibition of protein synthesis metabolic labeling experiments were conducted. 20 h post 582 transfection with 5 μg iPKR construct (with or without NS3/4A) and 10 μL reagent cells in 6-well plate were 583 labeled with 10 μCi TRAN 35 S label (MP Biomedicals) for 30 min following 30 min of starvation before the 584 addition of the label into L-methionine and L-cysteine-free DMEM media (Invitrogen). Equal amounts of protein 585 from extracts were separated by electrophoresis and transferred on a PVDF membrane. The membrane was 586 dried in 100% methanol and analyzed for autoradiography, later it was blotted with antibodies and finally 587 stained with Coomassie Plus stain (Pierce).
589
Bio-orthogonal non canonical amino acid tagging (BONCAT) ex vivo 590 Brain slices containing amygdala were prepared as described above and equilibrated in carboxygenated 1:1 591 cutting solution: ACSF (in mM 125 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 25 glucose, 1 MgCl 2 and 2 592 CaCl 2 ) for 20 min. Brain slices were further allowed to recover in ACSF at 31. 
600 Surface labeling of translation (SUnSET) in vivo 601
For SUnSET in vivo immunoblotting, Nes.iPKR mice were sequentially infused icv with 150 pg ASV (2 μl, 100 602 nM) infusion followed 15 min later with 25 μg puromycin. Brain slices were prepared as described above in 603 cutting solution and the amygdala was micro-dissected and stored at -80 o C until ready for homogenization in 604 lysis buffer (10 mM HEPES, 150 mM NaCl, 50 mM NaF, 1 mM EDTA, 1 mM EGTA, 10 mM Na4P2O7, 1% 605 Triton X-100, 0.1% SDS and 10% glycerol). 40 μg puromycylated protein lysate were subjected to Western 606 blots with anti-puromycin. For SUnSET in vivo immunohistochemistry, CamK2α.iPKR mice were infused 607 sequentially with ASV ((2 μl, 100 nM) icv followed 15 min later with puromycin (0.5 μl, 10 μg/μl) in the lateral 608 amygdala. 1h post puromycin infusion, animals were transcardially perfused with 0.1M PBS, 0.015% digitonin 609 followed by 4% paraformaldehyde in PBS.
611 Immunohistochemistry
612
Mice were deeply anesthetized with a mixture of ketamine (150 mg/kg ) and xylazine (15 mg/kg), and 613 transcardially perfused with 0.1M PBS followed by 4% paraformaldehyde in PBS. Brains were removed and 614 postfixed in 4% PFA for 24h. 40 μm free-floating coronal brain sections containing amygdala were collected 615 using Leica vibratome. After blocking in 5% normal goat serum in 0.1M PBS with 0.1% Triton X-100, brain 616 sections were probed overnight with primary antibodies (chicken anti-EGFP (abcam #ab13970), rabbit anti-617 EGFP (Thermo Fisher #G10362), rabbit anti-p-eIF2α S51 (Cell Signaling #3398), chicken anti-mCherry 618 (abcam #ab205402) and mouse anti-puromycin (Millipore #MABE343)). After washing three times in 0.1M 619 PBS, brain sections were incubated with Alexa Fluor conjugated secondary antibodies (1:200) in blocking 620 buffer for 1.5h at RT, and mounted using Prolong Gold antifade mountant with DAPI for nuclear counterstain.
621
Imaging data were acquired using an SP8 confocal microscope (Leica) with 10x and 20X objective lenses, and 622 analyzed with ImageJ using the Bio-Formats importer plugin. To quantify the p-eIF2α and puromycin signal 623 intensity of each GFP immunoreactive cell, z-stacks (10 optical sections with 0.563 μm step size) for three 624 coronal sections per mouse (n=3 mice) were collected with 20X objective with 2X zoom. All compared samples 625 were processed using the same protocol, and images were taken with equal microscope settings. Images were 626 analyzed using ImageJ software. To compare across groups all measures were normalized to the average 627 intensity of the control group. Drug: F(1,8) = 19.04, **p<0.0024; Genotype: F(1,8) = 120.4, ****p<0.0001. Major intracellular signaling 821 pathways, ERK1/2 MAPK and mTORC1, assessed by examining p-ERK1/2 (T202/Y204) and p-S6 (S240/244) 822 levels, were unchanged by ASV treatment in Nes.iPKR amygdala lysates. (n = 3-4 biological replicate lysates, 823 3-4 mice per group; Two-way ANOVA followed by post-hoc Bonferroni's test). e) Time course for ciPSI carried 824 out by collecting amygdala lysate at different time points following ASV infusion (0, 0.5h, 1h, 3h and 6h) shows 825 peak expression of 36 kDa iPKR at 0.5h, which was undetectable at 6h (****p<0.0001). Endogenous PKR (68 826 kDa) remained unchanged after ASV treatment. Peak expression of p-eIF2α, normalized for t-eIF2α, was 827 achieved at 0.5h after ASV infusion followed by a steady decline from 3h onwards (*p<0.05). ATF4 and 828 GADD34 proteins whose transcripts harbor a uORF, were increased by ASV by 1h and and decline to baseline 829 by 6h (***p<0.001 and **p<0.01). cFOS levels significantly declined from baseline at 3h and 6h post infusion Nes.iPKR amygdala slices treated with ASV (5 nM) applied before the tetanus and perfused for 90 min 835 following tetanus (****p<0.0001, n = 12-15 slices/ group). One-way ANOVA with Bonferroni's post-hoc test. g)
836
Mean fEPSPs at baseline (10 min) before ASV application, at 30 min (i.e. 10 min after ASV application), at 60 837 min (30 min after tetanus) and at 120 min (90 min after tetanus). ASV significantly reduced fEPSP slope in 838 Nes.iPKR amygdala at 120 min compared to vehicle treatment (***p<0.01) and ASV treated wild-type 839 amygdala (****p<0.001), but had no effect on baseline. Repeated measures Two-way ANOVA with 
